Results 51 to 60 of about 173,434 (149)
Regenerative Therapy, 2019 Introduction: The definitive treatment for severe heart failure is transplantation. However, only a small number of heart transplants are performed each year due to donor shortages.
Akitoshi Inui +8 more
doaj +1 more source
Scaffolds in vascular regeneration: current status
Vascular Health and Risk Management, 2015 Neelima Thottappillil, Prabha D Nair Division of Tissue Engineering and Regeneration Technologies, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala, IndiaAbstract: An ideal vascular substitute ...
Thottappillil N, Nair PD
doaj
Cell Transplantation, 2019 The survival of engineered tissue requires the formation of its own capillary network, which can anastomose with the host vasculature after transplantation.
Zhiming Jia +7 more
doaj +1 more source
Poly Lactic Acid Based Scaffolds for Vascular Tissue Engineering
Chemical Engineering Transactions, 2012 A critical obstacle encountered by tissue engineering is the inability to maintain large masses of living cells upon transfer from the in vitro culture conditions to host in vivo.
F. Carfì Pavia +5 more
doaj +1 more source
Lung Microvascular Niche, Repair, and Engineering
Frontiers in Bioengineering and Biotechnology, 2020 Biomaterials have been used for a long time in the field of medicine. Since the success of “tissue engineering” pioneered by Langer and Vacanti in 1993, tissue engineering studies have advanced from simple tissue generation to whole organ generation with
Tomoshi Tsuchiya +5 more
doaj +1 more source
Engineering vascularised tissues in vitro [PDF]
European Cells & Materials, 2008 Tissue engineering aims at replacing or regenerating tissues lost due to diseases or traumas (Langer and Vacanti, 1993). However, mimicking in vitro the physiological complexity of vascularized tissue is a major obstacle, which possibly contributes to ...
N C Rivron +4 more
doaj
Recellularization of Decellularized Venous Grafts Using Peripheral Blood: A Critical Evaluation
EBioMedicine, 2018 Vascular disease is a major cause of death worldwide, and the growing need for replacement vessels is not fully met by autologous grafts or completely synthetic alternatives.
Mia H. Rambøl +4 more
doaj +1 more source
Ginsenoside Rg1 promotes endothelialization of tissue-engineered blood vessels in transplanted rats
Di-san junyi daxue xuebao, 2020 Objective To prepare the endothelialization-promoting tissue-engineered blood vessels (TEBVs) with encapsulated Ginsenoside Rg1 (Rg1) to promote endothelialization, and to evaluate its patency and endothelialization after implantation into the rat common
WANG Tianran +5 more
doaj +1 more source
Utility of Telomerase-pot1 Fusion Protein in Vascular Tissue Engineering
Cell Transplantation, 2010 While advances in regenerative medicine and vascular tissue engineering have been substantial in recent years, important stumbling blocks remain. In particular, the limited life span of differentiated cells that are harvested from elderly human donors is
Thomas H. Petersen +10 more
doaj +1 more source
Generating vascular conduits: from tissue engineering to three-dimensional bioprinting
Innovative Surgical Sciences, 2018 Vascular disease – including coronary artery disease, carotid artery disease, and peripheral vascular disease – is a leading cause of morbidity and mortality worldwide.
Maina Renee M. +7 more
doaj +1 more source